ArticleCureus2026
When Blasts Speak Louder Than Flow: A Diagnostic Challenge in Suspected Hematologic Malignancy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early diagnosis of hematologic malignancies can be challenging when initial diagnostic studies are discordant, particularly because flow cytometry, although central to evaluation, may be non-diagnostic in evolving disease. We report the case of a 33-year-old female who presented with leukocytosis, systemic symptoms, and progressive hematologic abnormalities, including circulating blasts identified on peripheral blood analysis. Initial diagnostic evaluation included laboratory studies, peripheral smear review, and flow cytometry, followed by cross-sectional imaging that demonstrated an anterior mediastinal mass, lymphadenopathy, and hepatosplenomegaly concerning for lymphoproliferative malignancy. Despite strong clinical suspicion, early flow cytometric findings were insufficient for definitive classification, prompting escalation to bone marrow biopsy with comprehensive immunophenotypic and cytogenetic analysis. Bone marrow examination ultimately demonstrated T-lymphoblastic leukemia/lymphoma with an abnormal immature T-cell population and isolated
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.